0 treatment that improves ability of the immune system to fight disease:
Immunotherapy with interferons may be used in patients with infections that are very difficult to treat.
Teratogenic effects of neonatal arenavirus infection on the developing rat cerebellum are abrogated by passive immunotherapy.
Future therapies under investigation in the area of immunotherapy for neuroblastoma are considered.
Hence, it may be attractive to target the tumour environment rather than the tumour itself for immunotherapy.
Blocking or downregulation of these inhibitors could be an important step in the advancement of immunotherapy.
Overall, these observations support the idea that the cancer stem cell model may imply important therapeutic consequences, indicating new targets for pharmacological compounds or immunotherapy.
Given the nature of metastatic disease, immunotherapies seem particularly well suited for the treatment of this disseminated disease state.
In general, the route of administration for conventional immunotherapy is subcutaneous; however, local routes, most notably sublingual, are being investigated as an alternative.
Most cancer immunotherapies awaiting field trials have been principally aimed at activation of the host immune system to fight the growing neoplasm.
